If you are interested in learning more and would like to be considered for this Vascular Ehlers-Danlos Syndrome treatment study, please click on the orange “Learn More” button at the top right of the page. This button will take you to a new page where we will verify your name and contact information. We will also ask you a few questions that will determine if you may qualify for the Acer Vascular Ehlers-Danlos Syndrome treatment study with celiprolol. If you pre-qualify, a Science 37 Patient Experience Coordinator will contact you within 24 hours via a phone call to discuss the study in more detail and ask a few more questions to further assess your eligibility to participate in the Vascular Ehlers-Danlos Syndrome, DiSCOVER trial.
If you are eligible to participate in this Vascular Ehlers-Danlos Syndrome treatment study, you will participate entirely from home. You will have study visits where a registered nurse will visit your home and study visits conducted with a registered nurse online through a telehealth visit. You will be provided instructions for taking the investigational drug which will be shipped directly to your home. During your participation in the study you will continue your regularly scheduled visits with your primary doctor(s).